Skip to main content
. Author manuscript; available in PMC: 2024 Mar 5.
Published in final edited form as: Oncogene. 2023 Jun 5;42(27):2155–2165. doi: 10.1038/s41388-023-02738-y

Figure 2. Current single cell-based technologies available to study GBM heterogeneity.

Figure 2.

(A) Assays focused on in this review: single cell RNA sequencing (scRNA-seq), single nucleus RNA sequencing (snRNA-seq), single-cell sequencing Assay for Transposase-Accessible Chromatin (scATAC-seq), and single cell Spatial Transcriptomics (scST). (B) Other single cell assays: single cell DNA sequencing (scDNA-seq), Cytometry by Time of Flight (CyTOF), Time-Resolved Assessment of Protein Secretion from single cells by sequencing (TRAPS-seq), single cell T Cell Receptor sequencing (scTCR-seq), Transcript-indexed ATAC-seq (T-ATAC-seq), Cellular Indexing of Transcriptomes and Epitopes (CITE-seq), single cell Cap And Tail sequencing (scCAT-seq) and their read-outs.